drugset / Trial / NCT07175623

Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients

NCT07175623

Completed 60 enrolled Konya City Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized controlled trial aims to compare the interaction of methylprednisolone and dexamethasone with sugammadex in pediatric patients undergoing adenoidectomy and/or tonsillectomy. The primary objective is to evaluate the effect of these corticosteroids on the reversal time of rocuronium-induced neuromuscular block by sugammadex. Secondary outcomes include postoperative pain, nausea and vomiting, extubation time, and adverse events. Eligible participants are children aged 5 to 12 years, ASA I-II, scheduled for elective surgery under general anesthesia. The study is designed as a triple-blind, parallel-group trial with three arms: methylprednisolone, dexamethasone, and placebo.

Timeline

Start
2025-09-16
Primary completion
2025-12-20
Completion
2025-12-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.2 mg/kg Intravenous
Subject Methylprednisolone Other / unclassified 1 mg/kg Intravenous